Table 2.
Variables | Anterior STEMI | p-Value | |
---|---|---|---|
NO (n = 101) |
YES (n = 145) |
||
Age > 75 years (n, %) | 39 (39.8%) | 44 (30.1%) | 0.128 |
Female sex (n, %) | 34 (34.7%) | 39 (26.9%) | 0.193 |
Type II diabetes mellitus (n, %) | 21 (21.9%) | 25 (17.4%) | 0.348 |
Heart rate (bpm; median (Q1–Q3)) | 73 (62–82) | 80 (68–88) | <0.001 |
Anemia (n, %) | 43 (46.7%) | 61 (44.2%) | 0.075 |
Out of hospital cardiac arrest (n, %) | 29 (30.2%) | 61 (42.4%) | 0.057 |
Hyperglycemia (n, %) | 34 (39.5%) | 59 (44.7%) | 0.451 |
Creatine kinase peak (Mu/L; median (Q1–Q3)) | 1.2 (0.6–2.1) | 1.7 (0.8–3) | <0.001 |
Baseline white blood cells (n × 103/mcl; median (Q1–Q3)) | 10.8 (8.7–13.1) | 11.5 (9–14.2) | <0.001 |
Left ventricular ejection fraction (%; median(Q1–Q3)) | 40 (30–47) | 27 (20–37.5) | <0.001 |
Contrast-induced acute kidney injury (n, %) | 5 (5.4%) | 13 (9.3%) | <0.001 |
Bleeding (n, %) | 9 (9.6%) | 22 (15.6%) | <0.001 |
Three-vessel disease (n, %) | 33 (34.7%) | 53 (38.1%) | 0.597 |
Left main involvement (n, %) | 1(1.2%) | 16 (11.9%) | 0.004 |
Systolic blood pressure < 90 mmHg in the cath-lab (n, %) | 23 (25%) | 22 (16.7%) | 0.126 |
Post-procedural TIMI flow <3 (n, %) | 23 (23.7%) | 32 (23.2%) | 0.926 |
ST resolution (n, %) | 78 (78%) | 88 (61%) | <0.001 |